<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael S Calderwood, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anthony Harris, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The diagnosis of a catheter-related bloodstream infection (CRBSI) is based on epidemiologic, clinical, and laboratory criteria. The clinical features and diagnosis of CRBSI will be reviewed here. </p><p>Issues related to the epidemiology, pathogenesis, treatment, and prevention of CRBSI are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology"</a> and  <a class="medical medical_review" href="/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a> and  <a class="medical medical_review" href="/d/html/15671.html" rel="external">"Routine care and maintenance of intravenous devices"</a>.)</p><p>Issues related to infection associated with hemodialysis catheters are discussed separately. (See  <a class="medical medical_review" href="/d/html/1966.html" rel="external">"Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Management and prevention"</a> and  <a class="medical medical_review" href="/d/html/8180.html" rel="external">"Central venous catheters: Overview of complications and prevention in adults", section on 'Catheter-related infection'</a>.)</p><p class="headingAnchor" id="H3617934302"><span class="h1">DEFINITIONS FOR SURVEILLANCE</span><span class="headingEndMark"> — </span>To standardize surveillance, the United States Centers for Disease Control and Prevention introduced the term laboratory-confirmed bloodstream infection (LCBI) [<a href="#rid1">1</a>]. An LCBI must meet at least one of the following criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>Patient has a noncommensal bacterial or fungal pathogen cultured from one or more blood specimens, and the pathogen is not related to an infection at another site. Certain nonculture based microbiologic testing on blood specimens may also be used to meet this definition if they identify to the genus or species level; however, catheter tip cultures should not be used in place of blood specimens.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patient has a common commensal organism (eg, coagulase-negative staphylococcus) in two or more blood cultures collected on different days or from different sites that is not related to an infection at another site and that occurs in the setting of one of the following signs or symptoms: fever (&gt;38.0°C), chills, or hypotension.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients ≤1 year of age, signs and symptoms include: fever (&gt;38.0°C), hypothermia (&lt;36.0°C), apnea, and bradycardia.</p><p></p><p>For surveillance purposes, a central line-associated bloodstream infection (CLABSI) refers to a primary bloodstream infection (BSI) meeting at least one of the LCBI criteria above in a patient with a central line in place for &gt;2 consecutive calendar days [<a href="#rid1">1-3</a>]. Multiple studies have now identified the importance of validating publicly reported CLABSI rates due to variations in detection and reporting methods [<a href="#rid4">4,5</a>].</p><p>For clinical and research purposes, the diagnosis of a catheter-related bloodstream infection (CRBSI) is based on clinical and laboratory criteria that are stricter than those for CLABSI, in an effort to better ensure that the catheter is the source of the infection. Since some BSIs are due to sources other than the catheter which may not be easily recognized, the CLABSI surveillance definition may overestimate the true incidence of CRBSI secondary to central lines [<a href="#rid2">2</a>]. However, CRBSI may occur with any intravascular catheter, not just central lines.</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2323465075"><span class="h2">General presentation</span><span class="headingEndMark"> — </span>Clinical manifestations of catheter-related bloodstream infection (CRBSI) may include fever, inflammation, or purulence at the catheter insertion site, hemodynamic instability, and altered mental status. Catheter dysfunction (as occurs with intraluminal clot) may be observed. Clinical signs of sepsis that start abruptly after catheter infusion suggest infusate contamination. (See  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Infusate contamination'</a> and <a class="local">'Other specimens'</a> below.)</p><p>Fever and abrupt onset of septic physiology are the most common clinical manifestations of CRBSI; however, both are also associated with other causes of infection as well as noninfectious etiologies [<a href="#rid6">6</a>]. Presence of inflammation or purulence at the insertion site has high specificity (94 to 99 percent) but poor sensitivity (&lt;5 percent) for CRBSI  (<a class="graphic graphic_table graphicRef55700" href="/d/graphic/55700.html" rel="external">table 1</a>) [<a href="#rid7">7</a>]. </p><p>Local signs are absent in almost 60 percent of CRBSI, particularly with older age, critical illness, immunosuppression, catheters in place one week or less, and jugular/femoral sites. Local signs observed in the first seven days following insertion are highly predictive of CRBSI [<a href="#rid8">8,9</a>].</p><p>Clinical improvement within 24 hours following catheter removal is suggestive of CRBSI (but not sufficient for definitive diagnosis) [<a href="#rid10">10</a>]. Indications for catheter removal are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment", section on 'Selecting a catheter management strategy'</a>.) </p><p class="headingAnchor" id="H3517632843"><span class="h2">Complications</span><span class="headingEndMark"> — </span>CRBSI may be associated with complications including septic thrombophlebitis, infective endocarditis (IE), and metastatic infection. Clinical manifestations reflecting these complications may be present at the time of initial presentation and/or may develop subsequently. These conditions can occur in the context of CRBSI or independently of CRBSI:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Septic thrombophlebitis</strong> – Septic thrombophlebitis refers to venous thrombosis associated with inflammation in the setting of bacteremia; it should be suspected in patients with CRBSI and persistent bacteremia after 72 hours of appropriate therapy. Clinical manifestations may include fever, erythema, a palpable tender cord, and/or purulent drainage [<a href="#rid11">11-13</a>]. Complications include septic pulmonary emboli and secondary pneumonia; these may also be presenting manifestations of the infection [<a href="#rid14">14</a>]. The presence of venous thrombosis may be established via duplex ultrasonography [<a href="#rid15">15</a>]; the microbiologic diagnosis may be based on blood culture. (See  <a class="medical medical_review" href="/d/html/2131.html" rel="external">"Catheter-related septic thrombophlebitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infective endocarditis</strong> – IE refers to infection of one or more heart valves. IE should be suspected in patients with CRBSI or bacteremia &gt;48 to 72 hours with a pathogen associated with IE. (See  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.)</p><p></p><p class="bulletIndent1">Echocardiographic evaluation is warranted for patients with signs and symptoms of IE (eg, new murmur or embolic phenomena), persistent bacteremia, or the presence of a prosthetic valve or other endovascular foreign body [<a href="#rid16">16,17</a>]. Patients with <em>Staphylococcus aureus</em> bacteremia also warrant echocardiographic evaluation. Echocardiographic examination is not used routinely for infants and children with bacteremia or CRBSI who do not have other indicators of endocarditis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metastatic musculoskeletal infection</strong> (such as septic arthritis, osteomyelitis, orthopedic hardware infection) – Bacteremia may be associated with seeding of joints, bone, or orthopedic hardware. The diagnosis of septic arthritis should be suspected in patients with acute onset of at least one swollen, painful joint. Osteomyelitis should be suspected in the setting of new or worsening musculoskeletal pain. Orthopedic hardware infection should be suspected in the setting of pain at the site of prosthetic material. These conditions are discussed further separately. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a> and  <a class="medical medical_review" href="/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7664.html" rel="external">"Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3370704041"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>Blood cultures positive for an organism commonly associated with CRBSI (eg, <em>S. aureus</em>, coagulase-negative staphylococci, enterococci, <em>Candida</em> species, <em>Klebsiella</em> species, <em>E. coli</em>) should raise suspicion for CRBSI, particularly in the absence of other identifiable sources of infection [<a href="#rid18">18-21</a>]. (See <a class="local">'Interpreting blood culture results'</a> below.)</p><p>The microbiology of catheter infections is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Microbiology'</a>.)</p><p>Other laboratory tests (such as white blood cell count, C-reactive protein, procalcitonin) may provide clues to an infectious process but are not specific for CRBSI [<a href="#rid22">22-25</a>].</p><p class="headingAnchor" id="H3"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H117197607"><span class="h2">Clinical approach</span><span class="headingEndMark"> — </span>The diagnosis of catheter-related bloodstream infection (CRBSI) should be suspected in patients with fever, chills, or hypotension in the setting of a catheter placed at least 48 hours prior to development of symptoms; however, these manifestations are also associated with other causes of infection as well as noninfectious etiologies [<a href="#rid6">6</a>]. </p><p>Physical examination findings of erythema, pain, swelling, or purulence at the central line insertion site should also raise suspicion for CRBSI. Such patients should also be evaluated for signs and symptoms reflecting complications of CRBSI, including septic thrombophlebitis, endocarditis, and metastatic musculoskeletal infection (see <a class="local">'Complications'</a> above). In addition, patients with other indwelling devices (such as cardiac implantable electronic devices, orthopedic hardware, or vascular grafts) should be evaluated carefully for infections at these sites. (See  <a class="medical medical_review" href="/d/html/2146.html" rel="external">"Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7664.html" rel="external">"Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/14023.html" rel="external">"Arteriovenous graft creation for hemodialysis and its complications", section on 'Graft infection'</a>.)</p><p>In the setting of suspected CRBSI, blood cultures should be obtained, ideally prior to the initiation of antibiotic therapy [<a href="#rid26">26</a>]. (See <a class="local">'Collecting specimens for culture'</a> below.)</p><p>For patients who are clinically stable, antimicrobial therapy may be deferred while awaiting blood culture results. For patients with signs of clinical instability, initiation of empiric antimicrobial therapy (after blood cultures have been obtained) is appropriate. (See  <a class="medical medical_review" href="/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults", section on 'Empiric antibiotic therapy (first hour)'</a>.)</p><p>If blood cultures establish the presence of a bloodstream infection (BSI) (see <a class="local">'Interpreting blood culture results'</a> below), the patient should be evaluated for alternative sources. Clinical history and physical examination should be performed to evaluate for signs and symptoms suggestive of an alternative source for BSI (such as pulmonary, abdominal, urinary tract, bone/joint, or skin/soft tissue infection). Subsequent diagnostic evaluation should be guided by the clinical evaluation, tailored to individual circumstances; as an example, patients with focal joint pain and an effusion should undergo diagnostic joint aspiration to evaluate for septic arthritis. </p><p>Presence of <em>S. aureus</em> BSI should prompt evaluation as outlined separately. (See  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults"</a>.)</p><p>Clinical improvement within 24 hours following catheter removal is suggestive of CRBSI (but not sufficient for definitive diagnosis) [<a href="#rid10">10</a>]. Indications for catheter removal are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment", section on 'Selecting a catheter management strategy'</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Collecting specimens for culture</span></p><p class="headingAnchor" id="H856077609"><span class="h3">Blood cultures</span><span class="headingEndMark"> — </span>The blood culture bottles should be labeled to reflect the sites from which the cultures were obtained. Ideally, at least two sets of blood cultures should be obtained from peripheral veins via separate venipuncture sites prior to initiation of antibiotic therapy [<a href="#rid27">27,28</a>]. </p><p>For circumstances in which this is not feasible, one blood culture set may be drawn from a peripheral vein and the other blood culture set may be drawn from the catheter [<a href="#rid29">29</a>]. However, higher blood culture contamination rates when drawing off of a catheter can increase the rate of positive blood culture results, even when peripheral cultures are negative [<a href="#rid30">30</a>]. For this same reason, blood cultures should not be drawn solely from the catheter, since colonization with skin contaminants can reduce the specificity and the positive predictive value of the blood culture results [<a href="#rid26">26,31-33</a>]. </p><p>For blood culture collection through a catheter, cultures should be obtained from the catheter after removal of the old needleless connector (which was protected with an antiseptic barrier cap) or through a new connector after the old connector (protected by a barrier cap) is discarded [<a href="#rid31">31</a>]. In the setting of a multilumen catheter, it is uncertain whether blood cultures should be drawn through all catheter lumens [<a href="#rid34">34,35</a>]. </p><p>Catheter tip cultures are no longer recommended for CRBSI diagnosis, given low positive predictive value; historically, catheter tip cultures were part of CRBSI diagnostic criteria [<a href="#rid36">36-38</a>].</p><p>A dedicated phlebotomy team can help to standardize practice to reduce blood culture contamination rates [<a href="#rid39">39</a>]. In one study, education regarding the importance of obtaining blood cultures by venipuncture rather than from central lines was associated with a substantial reduction in blood culture contamination rates as well as cost savings [<a href="#rid40">40</a>]. Issues related to blood culture collection technique (including skin disinfection and adequate time for drying) are discussed separately. (See  <a class="medical medical_review" href="/d/html/2133.html" rel="external">"Detection of bacteremia: Blood cultures and other diagnostic tests"</a>.)</p><p class="headingAnchor" id="H1419439275"><span class="h3">Other specimens</span><span class="headingEndMark"> — </span>In the setting of suspected infusate contamination (eg, clinical signs of sepsis that start abruptly after catheter infusion), the infusate should be sent for culture. The diagnosis of infusate contamination is confirmed by isolation of the same organism from the infusate and percutaneous blood culture (often an uncommon gram-negative bacillus). (See  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Infusate contamination'</a>.)</p><p class="headingAnchor" id="H3930747464"><span class="h2">Interpreting blood culture results</span><span class="headingEndMark"> — </span>In the absence of other identifiable sources of infection, the following blood culture results may be attributed to CRBSI:</p><p class="bulletIndent1"><span class="glyph">●</span>One or more blood culture bottles positive for <em>S. aureus, </em>enterococci, Enterobacteriaceae (eg, <em>Escherichia coli</em>, <em>Klebsiella</em> species,<em> Enterobacter</em> species), <em>Pseudomonas aeruginosa</em>, <em>Candida</em> species</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more blood culture bottles positive for coagulase-negative staphylococci or other common commensals (eg, <em>Corynebacterium</em> species [not <em>Corynebacterium diphtheriae</em>], <em>Cutibacterium</em> species, <em>Bacillus</em> species [not <em>Bacillus anthracis</em>], viridans group streptococci)</p><p></p><p class="bulletIndent1">Interpreting blood cultures positive for coagulase-negativ<em>e Staphylococcus</em> (CoNS) can be challenging, since CoNS is both the most common blood culture contaminant as well as one of the most common causes of CRBSI. A high proportion of positive blood cultures performed on samples drawn from multiple sites (both peripherally and through the suspected catheter) is the best indicator for true CRBSI due to this organism [<a href="#rid19">19,41</a>]. </p><p></p><p>In the setting of a single catheter-drawn blood culture positive for coagulase-negative staphylococci or other potential skin contaminant, with concomitant negative peripheral-drawn blood cultures, the findings may be attributable to catheter colonization, rather than CRBSI. However, the culture results must be interpreted in the clinical context (eg, fever without other sources could be attributable to a catheter infection). Presence of persistent fever requires repeat blood cultures and repeat clinical evaluation for alternative sources of fever. (See <a class="local">'Collecting specimens for culture'</a> above and  <a class="medical medical_review" href="/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment", section on 'Management of catheter colonization'</a>.)</p><p>For circumstances in which peripheral blood cultures are not obtained, positive blood cultures obtained through a catheter may be presumed to reflect true infection, in the absence of other identifiable sources of infection and in the presence of correlating clinical symptoms.</p><p>Patients with positive blood culture results should be evaluated carefully for other sources of infection, as well as complications of CRBSI. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Comparing the time to positive culture between blood cultures drawn from a central line and blood cultures drawn peripherally (known as differential time to positivity [DTTP]) has been used as a tool for diagnosis of CRBSI, particularly in those with cancer [<a href="#rid42">42,43</a>], but the predictive value of this approach is uncertain [<a href="#rid1">1,44</a>]. The technique requires equal volumes of blood (from central line and peripheral vein) obtained for culture at the same time with accurate labeling. For providers who utilize this test, the DTTP is interpreted as evidence that the central line is infected if blood obtained from the peripheral vein starts growing bacteria &gt;2 hours after blood obtained from the central line.</p><p>While a negative DTTP result has been used to suggest an alternative source for gram-negative bacteremia in hematology patients with febrile neutropenia [<a href="#rid44">44</a>], the performance of this tool is poor for many common enteric gram-negative bacteria [<a href="#rid45">45</a>]. In addition, studies evaluating the two-hour cut off for diagnosing and excluding CRBSI have found conflicting results for <em>Candida</em> species and poor results for <em>S. aureus </em>[<a href="#rid46">46-51</a>].</p><p>The microbiology of catheter-associated infection is discussed separately. (See  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Microbiology'</a>.)</p><p class="headingAnchor" id="H3482026509"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In patients with suspected catheter-related bloodstream infection (CRBSI), alternative sources for bloodstream infection (BSI) must be considered carefully. This is particularly important because management of CRBSI may require catheter removal, which can be challenging in patients with surgically implantable intravascular devices and in patients with limited vascular access [<a href="#rid52">52</a>].</p><p>Issues related to diagnostic evaluation of BSI depends on the organism; issues related to bacteremia due to specific organisms are discussed further separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Coagulase-negative staphylococci (see  <a class="medical medical_review" href="/d/html/2137.html" rel="external">"Infection due to coagulase-negative staphylococci: Clinical manifestations"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>S. aureus</em> (see  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gram-negative bacilli (see  <a class="medical medical_review" href="/d/html/3149.html" rel="external">"Gram-negative bacillary bacteremia in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Candida</em> (see  <a class="medical medical_review" href="/d/html/2462.html" rel="external">"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults"</a>)</p><p></p><p>CRBSI may be associated with complications including septic thrombophlebitis, infective endocarditis, and metastatic infection. These conditions can occur in the context CRBSI or independently of CRBSI. (See <a class="local">'Complications'</a> above.)</p><p>Other potential causes of BSI include primary vascular graft infection and mycotic aneurysm:</p><p class="bulletIndent1"><span class="glyph">●</span>Primary vascular graft infection may present with bacteremia, fever, and localized physical findings (such as a draining sinus tract) or may develop secondarily in the context of hematogenous seeding. The diagnosis is based on blood cultures and radiographic imaging [<a href="#rid53">53</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mycotic aneurysm can develop when infection of the arterial wall causes development of a new aneurysm or when a pre-existing aneurysm becomes infected secondarily in the setting of bacteremia. The clinical manifestations depend upon the site of the aneurysm and may include a painful, pulsatile, and enlarging mass together with fever and malaise. The mass may be palpable or demonstrable only by imaging. The diagnosis of an aneurysm is based upon imaging (computed tomography), and infection is confirmed by culturing an organism from the blood and/or from the aneurysm wall. (See  <a class="medical medical_review" href="/d/html/2129.html" rel="external">"Overview of infected (mycotic) arterial aneurysm"</a>.)</p><p></p><p class="headingAnchor" id="H756862088"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117743.html" rel="external">"Society guideline links: Venous access"</a>.)</p><p class="headingAnchor" id="H115808396"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17165.html" rel="external">"Patient education: Central line infections (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Symptoms and signs of catheter-related bloodstream infection (CRBSI) may include fever, hemodynamic instability, and altered mental status. Catheter dysfunction (as occurs with intraluminal clot) may be observed. Clinical signs of sepsis that start abruptly after catheter infusion suggest infusate contamination. (See <a class="local">'General presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Complications of CRBSI includes infective endocarditis, septic thrombophlebitis, and metastatic musculoskeletal infection. These conditions can occur in the context CRBSI or independently of CRBSI. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Blood cultures positive for an organism commonly associated with CRBSI (such as <em>Staphylococcus aureus</em>, coagulase-negative staphylococci, enterococci, <em>Candida</em> species, <em>Klebsiella</em> species, and <em>E. coli</em>) should raise suspicion for CRBSI, particularly in the absence of other identifiable sources of infection. (See <a class="local">'Laboratory findings'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">The diagnosis of CRBSI should be suspected in patients with fever, chills, or hypotension in the setting of a catheter placed at least 48 hours prior to development of symptoms. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Obtaining blood cultures</strong> – Ideally, at least two sets of blood cultures should be obtained from peripheral veins via separate venipuncture sites prior to initiation of antibiotic therapy. For circumstances in which this is not feasible, one blood culture set may be drawn from a peripheral vein and the other blood culture set may be drawn from a catheter hub. Blood cultures should not be drawn solely from the catheter hub since this site is frequently colonized with skin contaminants. (See <a class="local">'Blood cultures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No role for routine catheter tip cultures</strong> – There is no role for routine catheter culture at the time of catheter removal; a positive catheter culture is not diagnostic of CRBSI. (See <a class="local">'Other specimens'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interpreting blood culture results</strong> – In the absence of other identifiable sources of infection, the following blood culture results may be attributed to CRBSI in the absence of an alternative etiology (see <a class="local">'Interpreting blood culture results'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One or more blood culture bottles positive for <em>S. aureus, </em>enterococci, Enterobacteriaceae (eg, <em>Escherichia coli</em>, <em>Klebsiella</em> species,<em> Enterobacter</em> species), <em>Pseudomonas aeruginosa</em> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One or more blood culture bottles positive for <em>Candida</em> species (except in premature neonates)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two or more blood culture bottles positive for coagulase-negative staphylococci or other common commensals (eg, <em>Corynebacterium</em> species [not <em>Corynebacterium diphtheriae</em>], <em>Bacillus</em> species [not <em>Bacillus anthracis</em>], <em>Cutibacterium</em> species, viridans group streptococci)</p><p></p><p class="headingAnchor" id="H2238667599"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Jeffrey Band, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">National Healthcare Safety Network. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line-Associated Bloodstream Infection). http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf (Accessed on February 17, 2023).</li><li class="breakAll">Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011). https://www.cdc.gov/infectioncontrol/guidelines/bsi/background/terminology.html (Accessed on February 17, 2023).</li><li><a class="nounderline abstract_t">Buetti N, Marschall J, Drees M, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2022; 43:553.</a></li><li><a class="nounderline abstract_t">Larsen EN, Gavin N, Marsh N, et al. A systematic review of central-line-associated bloodstream infection (CLABSI) diagnostic reliability and error. Infect Control Hosp Epidemiol 2019; 40:1100.</a></li><li><a class="nounderline abstract_t">Bagchi S, Watkins J, Pollock DA, et al. State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network. Am J Infect Control 2018; 46:1290.</a></li><li><a class="nounderline abstract_t">O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008; 36:1330.</a></li><li><a class="nounderline abstract_t">Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002; 30:2632.</a></li><li><a class="nounderline abstract_t">Buetti N, Ruckly S, Lucet JC, et al. Factors influencing local signs at catheter insertion site regardless of catheter-related bloodstream infections. Crit Care 2021; 25:71.</a></li><li><a class="nounderline abstract_t">Buetti N, Ruckly S, Lucet JC, et al. Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs. Crit Care 2020; 24:694.</a></li><li><a class="nounderline abstract_t">Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access. Curr Clin Top Infect Dis 1992; 12:83.</a></li><li><a class="nounderline abstract_t">Baker CC, Petersen SR, Sheldon GF. Septic phlebitis: a neglected disease. Am J Surg 1979; 138:97.</a></li><li><a class="nounderline abstract_t">O'Neill JA Jr, Pruitt BA Jr, Foley FD, Moncrief JA. Suppurative thrombophlebitis--a lethal complication of intravenous therapy. J Trauma 1968; 8:256.</a></li><li><a class="nounderline abstract_t">Khan EA, Correa AG, Baker CJ. Suppurative thrombophlebitis in children: a ten-year experience. Pediatr Infect Dis J 1997; 16:63.</a></li><li><a class="nounderline abstract_t">Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 1989; 68:85.</a></li><li><a class="nounderline abstract_t">Mertz D, Khanlari B, Viktorin N, et al. Less than 28 days of intravenous antibiotic treatment is sufficient for suppurative thrombophlebitis in injection drug users. Clin Infect Dis 2008; 46:741.</a></li><li><a class="nounderline abstract_t">Anderson DJ, Murdoch DR, Sexton DJ, et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection 2004; 32:72.</a></li><li><a class="nounderline abstract_t">Fernández-Guerrero ML, Herrero L, Bellver M, et al. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med 2002; 252:510.</a></li><li><a class="nounderline abstract_t">Shukrallah B, Hanna H, Hachem R, et al. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis 2007; 58:453.</a></li><li><a class="nounderline abstract_t">Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis 1990; 9:869.</a></li><li><a class="nounderline abstract_t">O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162.</a></li><li><a class="nounderline abstract_t">Weiner-Lastinger LM, Abner S, Edwards JR, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017. Infect Control Hosp Epidemiol 2020; 41:1.</a></li><li><a class="nounderline abstract_t">Schalk E, Hanus L, Färber J, et al. Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS). Ann Hematol 2015; 94:1451.</a></li><li><a class="nounderline abstract_t">Theodorou VP, Papaioannou VE, Tripsianis GA, et al. Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 2012; 12:247.</a></li><li><a class="nounderline abstract_t">Xu Y, Chen R, Qin W, et al. Early diagnostic value of serum procalcitonin levels for catheter-related blood stream infection in first-ever acute ischemic stroke patients. BMC Neurol 2020; 20:6.</a></li><li><a class="nounderline abstract_t">Zhou B, Zhu J, Mao Z, Liu L. Roles of Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Catheter-Related Bloodstream Infection in Severe Burn Injury Patients. Dis Markers 2018; 2018:5607932.</a></li><li><a class="nounderline abstract_t">Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.</a></li><li><a class="nounderline abstract_t">Washington JA 2nd, Ilstrup DM. Blood cultures: issues and controversies. Rev Infect Dis 1986; 8:792.</a></li><li><a class="nounderline abstract_t">Aronson MD, Bor DH. Blood cultures. Ann Intern Med 1987; 106:246.</a></li><li><a class="nounderline abstract_t">Chatzinikolaou I, Hanna H, Hachem R, et al. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 2004; 50:167.</a></li><li><a class="nounderline abstract_t">Snyder SR, Favoretto AM, Baetz RA, et al. Effectiveness of practices to reduce blood culture contamination: a Laboratory Medicine Best Practices systematic review and meta-analysis. Clin Biochem 2012; 45:999.</a></li><li><a class="nounderline abstract_t">Mermel LA. Drawing blood cultures through intravascular catheters: Controversy and update. Infect Control Hosp Epidemiol 2019; 40:457.</a></li><li><a class="nounderline abstract_t">Everts RJ, Vinson EN, Adholla PO, Reller LB. Contamination of catheter-drawn blood cultures. J Clin Microbiol 2001; 39:3393.</a></li><li><a class="nounderline abstract_t">Martinez JA, DesJardin JA, Aronoff M, et al. Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients. Crit Care Med 2002; 30:7.</a></li><li><a class="nounderline abstract_t">Guembe M, Rodríguez-Créixems M, Sánchez-Carrillo C, et al. How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections? Clin Infect Dis 2010; 50:1575.</a></li><li><a class="nounderline abstract_t">Franklin JA, Gaur AH, Shenep JL, et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 2004; 23:614.</a></li><li><a class="nounderline abstract_t">Peterson LR, Smith BA. Nonutility of catheter tip cultures for the diagnosis of central line-associated bloodstream infection. Clin Infect Dis 2015; 60:492.</a></li><li><a class="nounderline abstract_t">Lai YL, Adjemian J, Ricotta EE, et al. Dwindling Utilization of Central Venous Catheter Tip Cultures: An Analysis of Sampling Trends and Clinical Utility at 128 US Hospitals, 2009-2014. Clin Infect Dis 2019; 69:1797.</a></li><li><a class="nounderline abstract_t">Ulrich P, Lepak AJ, Chen DJ. Diagnostic and Therapeutic Utility of Positive Intravascular Catheter Tip Cultures. Microbiol Spectr 2022; 10:e0402222.</a></li><li><a class="nounderline abstract_t">Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 2005; 129:1222.</a></li><li><a class="nounderline abstract_t">Boyce JM, Nadeau J, Dumigan D, et al. Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting. Infect Control Hosp Epidemiol 2013; 34:1042.</a></li><li class="breakAll">Byers K, Anglim A, et al. Case fatality rate for catheter-related bloodstream infections (CRSBI): a meta-analysis [abstract 43]. In: Program and abstracts of the Fifth Annual Meeting of the Society for Hospital Epidemiology of America (San Diego). 1995:23.</li><li><a class="nounderline abstract_t">Tomlinson D, Mermel LA, Ethier MC, et al. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis 2011; 53:697.</a></li><li><a class="nounderline abstract_t">Abdelkefi A, Achour W, Ben Othman T, et al. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005; 35:397.</a></li><li><a class="nounderline abstract_t">Freeman JT, Elinder-Camburn A, McClymont C, et al. Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity. Infect Control Hosp Epidemiol 2013; 34:89.</a></li><li><a class="nounderline abstract_t">Orihuela-Martín J, Rodríguez-Núñez O, Morata L, et al. Performance of differential time to positivity as a routine diagnostic test for catheter-related bloodstream infections: a single-centre experience. Clin Microbiol Infect 2020; 26:383.e1.</a></li><li><a class="nounderline abstract_t">Bouzidi H, Emirian A, Marty A, et al. Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis. J Hosp Infect 2018; 99:192.</a></li><li><a class="nounderline abstract_t">Kaasch AJ, Rieg S, Hellmich M, et al. Differential time to positivity is not predictive for central line-related Staphylococcus aureus bloodstream infection in routine clinical care. J Infect 2014; 68:58.</a></li><li><a class="nounderline abstract_t">Park KH, Lee MS, Lee SO, et al. Diagnostic usefulness of differential time to positivity for catheter-related candidemia. J Clin Microbiol 2014; 52:2566.</a></li><li><a class="nounderline abstract_t">Bouza E, Alcalá L, Muñoz P, et al. Can microbiologists help to assess catheter involvement in candidaemic patients before removal? Clin Microbiol Infect 2013; 19:E129.</a></li><li><a class="nounderline abstract_t">Jo KM, Choi S, Jung KH, et al. Diagnostic usefulness of differential time to positivity in neutropenic cancer patients with suspected catheter-related candidemia. Med Mycol 2020; 58:137.</a></li><li><a class="nounderline abstract_t">Gits-Muselli M, Villiers S, Hamane S, et al. Time to and differential time to blood culture positivity for assessing catheter-related yeast fungaemia: A longitudinal, 7-year study in a single university hospital. Mycoses 2020; 63:95.</a></li><li><a class="nounderline abstract_t">Chaftari AM, Hachem R, Raad S, et al. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol 2018; 39:222.</a></li><li><a class="nounderline abstract_t">Wilson WR, Bower TC, Creager MA, et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation 2016; 134:e412.</a></li></ol></div><div id="topicVersionRevision">Topic 3813 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : National Healthcare Safety Network. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line-Associated Bloodstream Infection). http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf (Accessed on February 17, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.cdc.gov/infectioncontrol/guidelines/bsi/background/terminology.html" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011). https://www.cdc.gov/infectioncontrol/guidelines/bsi/background/terminology.html (Accessed on February 17, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35437133" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31362804" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A systematic review of central-line-associated bloodstream infection (CLABSI) diagnostic reliability and error.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29903420" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18379262" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12483050" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33596980" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Factors influencing local signs at catheter insertion site regardless of catheter-related bloodstream infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33317594" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1642805" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnosis and management of infections of implantable devices used for prolonged venous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/464215" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Septic phlebitis: a neglected disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4868813" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Suppurative thrombophlebitis--a lethal complication of intravenous therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9002104" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Suppurative thrombophlebitis in children: a ten-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2646510" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18233950" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Less than 28 days of intravenous antibiotic treatment is sufficient for suppurative thrombophlebitis in injection drug users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15057570" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472911" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17509805" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2073897" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21460264" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Guidelines for the prevention of intravascular catheter-related infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31767041" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25933677" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23043618" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31910808" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Early diagnostic value of serum procalcitonin levels for catheter-related blood stream infection in first-ever acute ischemic stroke patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30595763" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Roles of Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Catheter-Related Bloodstream Infection in Severe Burn Injury Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3538319" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Blood cultures: issues and controversies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3541726" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15541601" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22709932" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effectiveness of practices to reduce blood culture contamination: a Laboratory Medicine Best Practices systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30837006" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Drawing blood cultures through intravascular catheters: Controversy and update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11526188" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Contamination of catheter-drawn blood cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11902290" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20455693" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15247598" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25355902" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Nonutility of catheter tip cultures for the diagnosis of central line-associated bloodstream infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30882880" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Dwindling Utilization of Central Venous Catheter Tip Cultures: An Analysis of Sampling Trends and Clinical Utility at 128 US Hospitals, 2009-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36354344" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Diagnostic and Therapeutic Utility of Positive Intravascular Catheter Tip Cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16196507" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24018920" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24018920" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21890775" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15640824" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23221198" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31288101" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Performance of differential time to positivity as a routine diagnostic test for catheter-related bloodstream infections: a single-centre experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29432818" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23954613" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Differential time to positivity is not predictive for central line-related Staphylococcus aureus bloodstream infection in routine clinical care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24829236" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnostic usefulness of differential time to positivity for catheter-related candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23231412" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Can microbiologists help to assess catheter involvement in candidaemic patients before removal?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30927433" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Diagnostic usefulness of differential time to positivity in neutropenic cancer patients with suspected catheter-related candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31630462" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Time to and differential time to blood culture positivity for assessing catheter-related yeast fungaemia: A longitudinal, 7-year study in a single university hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29331162" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27737955" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
